GLENMARK PHARMACEUTICALS
Quarterly Results Analysis [Mar2025]
GLENMARK PHARMACEUTICALS Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹3,256 Cr | ₹3,388 Cr | ₹3,434 Cr | ₹3,244 Cr | ₹3,063 Cr | ₹2,507 Cr | ₹3,207 Cr | ₹3,036 Cr |
Expenses | ₹2,695 Cr | ₹2,787 Cr | ₹2,832 Cr | ₹2,656 Cr | ₹2,559 Cr | ₹2,715 Cr | ₹2,745 Cr | ₹2,599 Cr |
Operating Income | ₹561 Cr | ₹600 Cr | ₹602 Cr | ₹588 Cr | ₹504 Cr | ₹-209 Cr | ₹462 Cr | ₹437 Cr |
Other Income | ₹12 Cr | ₹31 Cr | ₹39 Cr | ₹31 Cr | ₹773 Cr | ₹45 Cr | ₹2 Cr | ₹20 Cr |
Interest | ₹67 Cr | ₹52 Cr | ₹48 Cr | ₹40 Cr | ₹149 Cr | ₹134 Cr | ₹121 Cr | ₹112 Cr |
Depreciation | ₹125 Cr | ₹123 Cr | ₹120 Cr | ₹118 Cr | ₹151 Cr | ₹147 Cr | ₹141 Cr | ₹142 Cr |
Profit Before Tax | ₹8 Cr | ₹456 Cr | ₹473 Cr | ₹462 Cr | ₹531 Cr | ₹-521 Cr | ₹-124 Cr | ₹151 Cr |
Profit After Tax | ₹4 Cr | ₹348 Cr | ₹354 Cr | ₹340 Cr | ₹-1,239 Cr | ₹-450 Cr | ₹-180 Cr | ₹38 Cr |
EPS | ₹0.16 | ₹12.33 | ₹12.55 | ₹12.06 | ₹-43.17 | ₹-12.45 | ₹-2.90 | ₹5.31 |
Industry Peers & Returns | 1W | 1M | 1Y |
GLENMARK PHARMACEUTICALS | 4.2% | 20.3% | 39.7% |
SUN PHARMACEUTICAL INDUSTRIES | 0.9% | -0.1% | 10.9% |
DIVIS LABORATORIES | 3.7% | 3% | 46.5% |
CIPLA | 0.2% | 2.8% | 1.6% |
TORRENT PHARMACEUTICALS | 7.3% | 7.4% | 19.8% |
DR REDDYS LABORATORIES | -4% | 2.6% | 7.2% |
MANKIND PHARMA | 0.6% | -6.1% | 9.3% |
ZYDUS LIFESCIENCES | 2.6% | 6.4% | -8% |
LUPIN | 0.4% | -1.1% | 22.2% |
GLENMARK PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -3.88 % |
Y-o-Y | 6.31 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹3,256 Cr | -3.88 | |
Dec2024 | ₹3,388 Cr | -1.35 | |
Sep2024 | ₹3,434 Cr | 5.84 | |
Jun2024 | ₹3,244 Cr | 5.92 | |
Mar2024 | ₹3,063 Cr | 22.19 | |
Dec2023 | ₹2,507 Cr | -21.85 | |
Sep2023 | ₹3,207 Cr | 5.64 | |
Jun2023 | ₹3,036 Cr | - |
GLENMARK PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -6.53 % |
Y-o-Y | 11.24 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹561 Cr | -6.53 | |
Dec2024 | ₹600 Cr | -0.28 | |
Sep2024 | ₹602 Cr | 2.33 | |
Jun2024 | ₹588 Cr | 16.63 | |
Mar2024 | ₹504 Cr | Positive | |
Dec2023 | ₹-209 Cr | Negative | |
Sep2023 | ₹462 Cr | 5.70 | |
Jun2023 | ₹437 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -2.77 % |
Y-o-Y | 4.61 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 17.23% | -2.77 | |
Dec2024 | 17.72% | 1.08 | |
Sep2024 | 17.53% | -3.31 | |
Jun2024 | 18.13% | 10.08 | |
Mar2024 | 16.47% | Positive | |
Dec2023 | -8.32% | Negative | |
Sep2023 | 14.41% | 0.00 | |
Jun2023 | 14.41% | - |
GLENMARK PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -98.74 % |
Y-o-Y | Positive |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹4 Cr | -98.74 | |
Dec2024 | ₹348 Cr | -1.82 | |
Sep2024 | ₹354 Cr | 4.19 | |
Jun2024 | ₹340 Cr | Positive | |
Mar2024 | ₹-1,239 Cr | Negative | |
Dec2023 | ₹-450 Cr | Negative | |
Sep2023 | ₹-180 Cr | Negative | |
Jun2023 | ₹38 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -98.73 % |
Y-o-Y | Positive |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 0.13 % | -98.73 | |
Dec2024 | 10.27 % | -0.48 | |
Sep2024 | 10.32 % | -1.62 | |
Jun2024 | 10.49 % | Positive | |
Mar2024 | -40.44 % | Negative | |
Dec2023 | -17.94 % | Negative | |
Sep2023 | -5.62 % | Negative | |
Jun2023 | 1.24 % | - |
GLENMARK PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -98.70 % |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹0.16 | -98.70 | |
Dec2024 | ₹12.33 | -1.75 | |
Sep2024 | ₹12.55 | 4.06 | |
Jun2024 | ₹12.06 | Positive | |
Mar2024 | ₹-43.17 | Negative | |
Dec2023 | ₹-12.45 | Negative | |
Sep2023 | ₹-2.9 | Negative | |
Jun2023 | ₹5.31 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD